Abstract
Proton magnetic resonance imaging enables non-invasive monitoring of lesion formation in multiple sclerosis and has an important role in assessing the potential effects of therapy. T2-weighted and short tau inversion recovery magnetic resonance imaging were used to assess the effect of a neurotrophic adrenocorticotrophic hormone4-9 analogue [H-Met(O2)-Glu-His-Phe--Lys-Phe-OH] on the volume
... read more